We focused on inflammatory bowel diseases (IBD) [33] and rheumatoid arthritis (RA) [34], two IMIDs with worldwide growing prevalence, as well as on the infectious COVID-19 disease [35], a recent major healthcare issue, and involving the TLR7/8 signaling pathways [36]. Here, TLR7 is linked to inflammatory bowel disease.